TSS
CVS icon

Two Sigma Securities’s CVS Health CVS Stock Holding History

Two Sigma Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-213,000
Closed -$13.4M – 1981
2024
Q3 		$13.4M Buy
213,000
+6,100
+3% +$356K 0.23% 99
2024
Q2 		$12.2M Buy
206,900
+6,100
+3% +$382K 0.15% 167
2024
Q1 		$16M Sell
200,800
-19,500
-9% -$1.49M 0.15% 156
2023
Q4 		$17.4M Buy
220,300
+9,500
+5% +$676K 0.17% 125
2023
Q3 		$14.7M Buy
210,800
+47,900
+29% +$3.39M 0.16% 129
2023
Q2 		$11.3M Buy
162,900
+68,000
+72% +$4.84M 0.17% 131
2023
Q1 		$7.05M Buy
94,900
+89,800
+1,761% +$7.53M 0.14% 166
2022
Q4 		$475K Sell
5,100
-12,400
-71% -$1.2M 0.01% 1129
2022
Q3 		$1.67M Sell
17,500
-43,000
-71% -$4.26M 0.05% 425
2022
Q2 		$5.61M Buy
60,500
+28,400
+88% +$2.77M 0.2% 116
2022
Q1 		$3.25M Buy
32,100
+24,700
+334% +$2.59M 0.11% 220
2021
Q4 		$763K Sell
7,400
-7,200
-49% -$665K 0.03% 352
2021
Q3 		$1.24M Sell
14,600
-11,700
-44% -$980K 0.04% 424
2021
Q2 		$2.19M Buy
26,300
+19,000
+260% +$1.56M 0.07% 220
2021
Q1 		$549K Sell
7,300
-17,700
-71% -$1.29M 0.03% 259
2020
Q4 		$1.71M Sell
25,000
-1,700
-6% -$111K 0.04% 271
2020
Q3 		$1.56M Sell
26,700
-400
-1% -$24.9K 0.03% 255
2020
Q2 		$1.76M Buy
27,100
+5,100
+23% +$321K 0.04% 257
2020
Q1 		$1.3M Sell
22,000
-119,100
-84% -$7.95M 0.03% 333
2019
Q4 		$10.5M Buy
141,100
+12,200
+9% +$857K 0.07% 217
2019
Q3 		$8.13M Buy
128,900
+70,700
+121% +$4.19M 0.07% 200
2019
Q2 		$3.17M Sell
58,200
-29,600
-34% -$1.59M 0.03% 334
2019
Q1 		$4.74M Buy
87,800
+52,100
+146% +$3.22M 0.04% 178
2018
Q4 		$2.34M Sell
35,700
-50,400
-59% -$3.76M 0.03% 316
2018
Q3 		$6.78M Sell
86,100
-40,000
-32% -$2.86M 0.04% 300
2018
Q2 		$8.12M Sell
126,100
-59,300
-32% -$3.91M 0.04% 339
2018
Q1 		$11.5M Buy
185,400
+173,300
+1,432% +$12.4M 0.06% 255
2017
Q4 		$877K Buy
+12,100
New +$880K 0.02% 462

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Securities's CVS Position: Q1 2026 in Review

Two Sigma Securities opened a new position in CVS Health (CVS) in Q1 2026: 15,040 shares worth $1.08M. The stake represents 0.13% of the portfolio and ranks #196 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CVS as recently as Q3 2025.

Two Sigma Securities first reported a position in CVS in Q2 2015 and has held it in 30 quarters since. The position peaked at $12.8M in Q3 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Two Sigma Securities held 15,040 shares of CVS Health worth $1.08M as of Q1 2026.
  • CVS Health was a new Two Sigma Securities position in Q1 2026.
  • CVS Health made up 0.13% of Two Sigma Securities's portfolio in Q1 2026, its #196 holding.
  • Two Sigma Securities first reported a position in CVS Health in Q2 2015 and has held it in 30 quarters since.
  • Two Sigma Securities's CVS Health position peaked at $12.8M in Q3 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.